*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A case report on Deflazacort Induced Stevens Johnson Syndrome/Toxic Epidermal Necrolysis Overlap

Author: VADDE VINUSHA, DIVYA REDDY GADWALA, JUMANA HAKIM, ABHISHEK TIWARI, DR. RAMYA BALAPRABHA, VARSHA K.L.
Abstract: Deflazacort (DFZ) is an adrenal Glucocorticoid. DFZ is a prodrug of the corticosteroid active metabolite 21-des DFZ, which has anti-inflammatory and immunosuppressive effects via action on the glucocorticoid receptor. Deflazacort has been widely used instead of prednisone and prednisolone for managing nephrotic syndrome because of its equivalent anti-inflammatory efficacy to prednisolone. SJS-TEN is a potentially life-threatening dermatologic disorder and a severe cutaneous ADR that involves skin and mucous membrane. characterized by widespread erythema, necrosis and bullous detachment, resulting in exfoliation and possible sepsis and/or death. Which is most commonly drug induced, SJS-TEN is characterized by inappropriate immune activation in response to certain medications or their metabolites. The exact pathogenic mechanism of SJS-TEN is still uncertain. The exposure of drugs has increased with demographic shifts associated with a higher morbidity of the population. Along with this phenomenon, a rise in the incidence of the adverse drug reactions (ADRs) has been observed. Although steroids are used for the treating SJS-TEN. It is essential to understand its potential adverse effects. This rare case report addresses the fact that severe hypersensitivity reactions can occur with Deflazacort, which can be potentially dangerous and life threatening, this case report also adds a note on the diagnosis and management of SJS-TEN.
Keyword: Stevens Johnson Syndrome [SJS], Toxic Epidermal Necrolysis [TEN], Deflazacort [DFZ].
DOI: https://doi.org/10.31838/ijpr/2021.13.02.394
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free